Status and phase
Conditions
Treatments
About
The primary purpose of this study is to evaluate the change at the 18th week from baseline in daily "off" time measured by participant diary and Parkinson's Disease Questionnaire-39 (PDQ-39) in participants with Parkinson's Disease who are receiving levodopa.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
201 participants in 1 patient group
Loading...
Central trial contact
Elena Yoona Lee
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal